phenylbutazone has been researched along with Atrophy in 2 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DEGEN, CE | 1 |
| KAMP, KH | 1 |
| WOLLWEBER, A | 1 |
2 other studies available for phenylbutazone and Atrophy
| Article | Year |
|---|---|
[ON THE TREATMENT OF SUDECK'S SYNDROME WITH DELTABUTAZOLIDIN].
Topics: Atrophy; Blood Sedimentation; Chlorthalidone; Humans; Phenylbutazone; Physical Therapy Modalities; P | 1963 |
[CLINICAL EXPERIENCES WITH PHENYLBUTAZONE. THERAPEUTIC ACTION AND SIDE-EFFECTS].
Topics: Arthritis; Arthritis, Rheumatoid; Atrophy; Biomedical Research; Bronchitis; Fever; Gout; Hodgkin Dis | 1964 |